Nymox Pharmaceutical
NYMX
#10337
Rank
HK$0.14 B
Marketcap
Country
HK$1.57
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -HK$17.02 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -HK$51.1 Million, an increase over its 2021 earnings that were of -HK$97.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -HK$17.02 Million-66.7%
2022 -HK$51.1 Million-47.71%
2021 -HK$97.72 Million6.61%
2020 -HK$91.66 Million-10.91%
2019 -HK$0.11 Billion24.24%
2018 -HK$82.81 Million-20.03%
2017 -HK$0.11 Billion2.71%
2016 -HK$0.11 Billion-63.86%
2015 -HK$0.28 Billion674.44%
2014 -HK$36.03 Million-6.11%
2013 -HK$38.37 Million-35.66%
2012 -HK$59.64 Million-20.76%
2011 -HK$75.26 Million38.33%
2010 -HK$54.41 Million35.59%
2009 -HK$40.13 Million11.8%
2008 -HK$35.9 Million-12.94%
2007 -HK$41.23 Million8.85%
2006 -HK$37.88 Million36.5%
2005 -HK$27.75 Million-4.4%
2004 -HK$29.03 Million-14.58%
2003 -HK$33.98 Million
2001 -HK$24.93 Million-20.54%
2000 -HK$31.37 Million21.72%
1999 -HK$25.78 Million-25.56%
1998 -HK$34.63 Million101.3%
1997 -HK$17.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.39 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$82.92 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.70 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$243.68 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$10.77 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA